Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04240106
Title Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedSIR

Her2-receptor negative breast cancer



Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Centro Oncologico de Galicia Recruiting A Coruña 15009 Spain Details
Hospital Uniersitario Vall d'Hebron Recruiting Barcelona 08035 Spain Details
Hospital Clínic i provincial de Barcelona Recruiting Barcelona 08036 Spain Details
Hospital Universitario Reina Sofía Recruiting Córdoba 28091 Spain Details
Hospital Clinico San Carlos Recruiting Madrid 28041 Spain Details
Hospital Universitario 12 de octubre Recruiting Madrid 28041 Spain Details
Hospital Universitario Virgen de la Victoria Not yet recruiting Málaga 29010 Spain Details
Hospital Clínico Universitario de Santiago de Compostela Recruiting Santiago De Compostela 15706 Spain Details
Instituto Valenciano de Oncología Recruiting Valencia 46009 Spain Details
Complejo Asistencial de Ávila Recruiting Ávila 05071 Spain Details
*Shaded cells indicate that there was no data available from for the field